Mycophenolate mofetil is approved by the U.S. Food and Drug Administration (FDA) to prevent organ rejection in people who have received a kidney, heart, or liver transplant. This medicine comes as a capsule, tablet, or liquid that is taken by mouth. Researchers are currently studying MMF in combination with other medicines for treating aplastic anemia.
Mycophenolate Mofetil
A drug that lowers the body's immune response, also referred to as an immunosuppressant drug.